Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 65

Cited In for PubMed (Select 12831921)

1.

Metastatic glucagonoma.

Dinc B, Sahin C.

Eurasian J Med. 2009 Apr;41(1):70-2.

2.

Update on pancreatic neuroendocrine tumors.

McKenna LR, Edil BH.

Gland Surg. 2014 Nov;3(4):258-75. doi: 10.3978/j.issn.2227-684X.2014.06.03. Review.

3.

Curative versus palliative surgical resection of liver metastases in patients with neuroendocrine tumors: a meta-analysis of observational studies.

Bacchetti S, Pasqual EM, Bertozzi S, Londero AP, Risaliti A.

Gland Surg. 2014 Nov;3(4):243-51. doi: 10.3978/j.issn.2227-684X.2014.02.05.

4.

Role of surgery and transplantation in the treatment of hepatic metastases from neuroendocrine tumor.

Alagusundaramoorthy SS, Gedaly R.

World J Gastroenterol. 2014 Oct 21;20(39):14348-58. doi: 10.3748/wjg.v20.i39.14348. Review.

5.

Surgical treatment of liver metastases in patients with neuroendocrine tumors.

Saeed A, Buell JF, Kandil E.

Ann Transl Med. 2013 Apr;1(1):6. doi: 10.3978/j.issn.2305-5839.2013.01.08. Review.

6.

Update on surgical treatment of pancreatic neuroendocrine neoplasms.

D'Haese JG, Tosolini C, Ceyhan GO, Kong B, Esposito I, Michalski CW, Kleeff J.

World J Gastroenterol. 2014 Oct 14;20(38):13893-8. doi: 10.3748/wjg.v20.i38.13893. Review.

7.

Insulinoma: A rare cause of hypoglycemia in a young female.

Kelash F, Mulinda J.

J Community Hosp Intern Med Perspect. 2014 Sep 29;4(4). doi: 10.3402/jchimp.v4.25093. eCollection 2014.

8.

Gene expression accurately distinguishes liver metastases of small bowel and pancreas neuroendocrine tumors.

Sherman SK, Maxwell JE, Carr JC, Wang D, Bellizzi AM, Sue O'Dorisio M, O'Dorisio TM, Howe JR.

Clin Exp Metastasis. 2014 Dec;31(8):935-44. doi: 10.1007/s10585-014-9681-2. Epub 2014 Sep 21.

PMID:
25241033
9.

GASTROENTEROPANCREATIC NEUROENDOCRINE TUMORS (GEP-NETs) - APPROACH TO DIAGNOSIS AND MANAGEMENT.

Oladejo AO.

Ann Ib Postgrad Med. 2009 Dec;7(2):29-33. No abstract available.

10.

Pancreatic fistulae after pancreatic resections for neuroendocrine tumours compared with resections for other lesions.

Atema JJ, Jilesen AP, Busch OR, van Gulik TM, Gouma DJ, Nieveen van Dijkum EJ.

HPB (Oxford). 2015 Jan;17(1):38-45. doi: 10.1111/hpb.12319. Epub 2014 Jul 18.

PMID:
25041879
11.

Pancreastatin predicts survival in neuroendocrine tumors.

Sherman SK, Maxwell JE, O'Dorisio MS, O'Dorisio TM, Howe JR.

Ann Surg Oncol. 2014 Sep;21(9):2971-80. doi: 10.1245/s10434-014-3728-0. Epub 2014 Apr 22.

PMID:
24752611
12.
13.

Giant hepatic carcinoid: a rare tumor with a favorable prognosis.

Landen S, Elens M, Vrancken C, Nuytens F, Meert T, Delugeau V.

Case Rep Surg. 2014;2014:456509. doi: 10.1155/2014/456509. Epub 2014 Feb 9.

14.

When should a liver resection be performed in patients with liver metastases from neuroendocrine tumours? A systematic review with practice recommendations.

Lesurtel M, Nagorney DM, Mazzaferro V, Jensen RT, Poston GJ.

HPB (Oxford). 2015 Jan;17(1):17-22. doi: 10.1111/hpb.12225. Epub 2014 Mar 17.

PMID:
24636662
15.

Long term survival analysis of hepatectomy for neuroendocrine tumour liver metastases.

Cheung TT, Chok KS, Chan AC, Tsang S, Dai JW, Lang BH, Yau T, Chan SC, Poon RT, Fan ST, Lo CM.

ScientificWorldJournal. 2014 Jan 12;2014:524045. doi: 10.1155/2014/524045. eCollection 2014.

16.

Gastric inhibitory polypeptide receptor (GIPR) is a promising target for imaging and therapy in neuroendocrine tumors.

Sherman SK, Carr JC, Wang D, O'Dorisio MS, O'Dorisio TM, Howe JR.

Surgery. 2013 Dec;154(6):1206-13; discussion 1214. doi: 10.1016/j.surg.2013.04.052.

17.

Hepatic pseudocystic metastasis of well-differentiated ileal neuroendocrine tumor: a case report with review of the literature.

Fiori S, Del Gobbo A, Gaudioso G, Caccamo L, Massironi S, Cavalcoli F, Bosari S, Ferrero S.

Diagn Pathol. 2013 Sep 13;8:148. doi: 10.1186/1746-1596-8-148. Review.

18.

Consensus guidelines for the management and treatment of neuroendocrine tumors.

Kunz PL, Reidy-Lagunes D, Anthony LB, Bertino EM, Brendtro K, Chan JA, Chen H, Jensen RT, Kim MK, Klimstra DS, Kulke MH, Liu EH, Metz DC, Phan AT, Sippel RS, Strosberg JR, Yao JC; North American Neuroendocrine Tumor Society.

Pancreas. 2013 May;42(4):557-77. doi: 10.1097/MPA.0b013e31828e34a4.

19.

Molecular and therapeutic advances in the diagnosis and management of malignant pheochromocytomas and paragangliomas.

Lowery AJ, Walsh S, McDermott EW, Prichard RS.

Oncologist. 2013;18(4):391-407. doi: 10.1634/theoncologist.2012-0410. Epub 2013 Apr 10. Review.

20.

Neuroendocrine tumors arising in Meckel's diverticula: frequency of advanced disease warrants aggressive management.

Lorenzen AW, O'Dorisio TM, Howe JR.

J Gastrointest Surg. 2013 Jun;17(6):1084-91. doi: 10.1007/s11605-013-2191-8. Epub 2013 Apr 5.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk